ELIZABETH TURBEVILLE: Open Payments
NPI 1154048262 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,720 in 168 payments from 18 companies in 2025. Trend: 2023 $772 · 2024 $3,029 · 2025 $3,720
Food & beverage: $3,630Education: $90
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 32 | $557 |
| Janssen Biotech, Inc. | 16 | $540 |
| ABBVIE INC. | 24 | $528 |
| Regeneron Healthcare Solutions, Inc. | 8 | $351 |
| LEO Pharma Inc. | 18 | $334 |
| Lilly USA, LLC | 10 | $288 |
| PFIZER INC. | 12 | $187 |
| Novartis Pharmaceuticals Corporation | 7 | $166 |
| GENZYME CORPORATION | 7 | $163 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $151 |
Products named: TREMFYA, Bimzelx, DUPIXENT, SKYRIZI, RINVOQ, CIBINQO, ANZUPGO, ADBRY.
Industry payments across AR — which companies pay providers there.
